Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(12 sites)

United States

Beverly Hills Cancer Center, Beverly Hills, California

UC San Diego Moores Cancer Center, La Jolla, California

Sylvester Comprehensive Cancer Center (University of Miami Hospital and Clinics), Miami, Florida

Moffitt Cancer Center, Tampa, Florida

University of Maryland Medical Center, Baltimore, Maryland